U.S. flag

An official website of the United States government

NM_000064.4(C3):c.193A>C (p.Lys65Gln) AND not specified

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Mar 4, 2025
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003320186.4

Allele description [Variation Report for NM_000064.4(C3):c.193A>C (p.Lys65Gln)]

NM_000064.4(C3):c.193A>C (p.Lys65Gln)

Gene:
C3:complement C3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.3
Genomic location:
Preferred name:
NM_000064.4(C3):c.193A>C (p.Lys65Gln)
Other names:
p.Lys65Gln
HGVS:
  • NC_000019.10:g.6719285T>G
  • NG_009557.1:g.6367A>C
  • NM_000064.4:c.193A>CMANE SELECT
  • NP_000055.2:p.Lys65Gln
  • LRG_27:g.6367A>C
  • NC_000019.9:g.6719296T>G
  • NM_000064.3:c.193A>C
Protein change:
K65Q
Links:
dbSNP: rs539992721
NCBI 1000 Genomes Browser:
rs539992721
Molecular consequence:
  • NM_000064.4:c.193A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004024318Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 4, 2025)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

SCV005885324Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Feb 24, 2025)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality.

Ardissino G, Longhi S, Porcaro L, Pintarelli G, Strumbo B, Capone V, Cresseri D, Loffredo G, Tel F, Salardi S, Sgarbanti M, Martelli L, Rodrigues EM, Borsa-Ghiringhelli N, Montini G, Seia M, Cugno M, Carfagna F, Consonni D, Tedeschi S.

Kidney Int Rep. 2021 Jun;6(6):1614-1621. doi: 10.1016/j.ekir.2021.03.885.

PubMed [citation]
PMID:
34169201
PMCID:
PMC8207326

Autoimmunity and recurrent infections in partial complement C3 immunodeficiency.

Rodriguez-Marco A, Bradbury M, Riley P, Arkwright PD.

Rheumatology (Oxford). 2010 May;49(5):1017-9. doi: 10.1093/rheumatology/kep444. Epub 2010 Jan 4. No abstract available.

PubMed [citation]
PMID:
20047980
See all PubMed Citations (10)

Details of each submission

From Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, SCV004024318.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV005885324.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

Variant summary: C3 c.193A>C (p.Lys65Gln) results in a conservative amino acid change located in the MG2 domain of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.8e-05 in 251474 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in C3 causing C3 Deficiency (4.8e-05 vs 0.0011), allowing no conclusion about variant significance. c.193A>C has been reported in the literature in multiple heterozygous individuals affected with atypical Haemolytic uraemic syndrome without strong evidence of segregation (examples: Volokhina_2012, Duvvari_2014, Fidalgo_2017, Wilson_2020, Akesson_2021, Ardissino_2021). These report(s) do not provide unequivocal conclusions about association of the variant with C3 Deficiency. At least one publication reports experimental evidence evaluating an impact on protein function, however, does not allow convincing conclusions about the variant effect (Volokhina_2012). The following publications have been ascertained in the context of this evaluation (PMID: 22669319, 24736606, 30046676, 35372954, 33609329, : 34169201). ClinVar contains an entry for this variant (Variation ID: 381739). Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 11, 2026